test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

test
test
test

Marketing
Conferencee 2018

17 - 25 October 2018 | Tobacco Dock, London

REGISTER NOWREGISTER NOW

Aug 24–28
2020

DELIVERED DIGITALLY

Aug 24–28
2020
delivered digitally

Novel Antimicrobials & AMR Diagnostics

4th AMR Conference

AMR Conference

What you can expect

The AMR Conference is a platform to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to market.

More than 400 participants from 25+ countries

High-level panels and expert sessions > live and on-demand

Scientific poster presentations

A wide variety of topics from financing, development & regulation

Virtual 1:1 partnering meetings

SMEs, academics & governmental agencies benefit from discounted fees

2019 Event Highlights

Event Impressions & Testimonials

More than 330 experts joined the 2-day AMR Conference 2019 in Berlin. They called for rapid capital investments and economic incentives in the fight against antimicrobial resistance (AMR). The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, clinicians, investors, public stakeholders and policy-makers to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

Latest News

in the AMR and antimicrobial space

Cost-efficient and green manufacturing of peptides thanks to Molecular Hiving technology™

Bachem and Jitsubo CO., LTD. recently announced the signature of an exclusive Licensing Agreement for Jitsubo’s…

Spanish vaccine company Vaxdyn receives CARB-X funding

CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent infections that cause…

AMR Action Fund: A $1b down payment from Industry

The AMR Action Fund expects to invest more than US$1 billion in smaller biotech companies and…

We thank our Sponsors & Partners

Supporting Partners

Media Partners